Efficacy of Slim339® in reducing body weight of overweight and obese human subjects

Phytotherapy Research

Volumn 21, Issue 12, 2007, Pages 1177-1181

  Toromanyan, Edward ^a   Aslanyan, Gayane ^b   Amroyan, Elmira ^a   Gabrielyan, Emil ^a   Panossian, Alexander ^c  

^a Armenian Ministry of Health   (Armenia)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c Swedish Herbal Institute   (Sweden)

Author keywords

Calcium pantothenate; Clinical trial; Dietary supplement; Garcinia cambogia; Obesity; Overweight; Slim339

Indexed keywords

HERBACEOUS AGENT; PLACEBO; PLANT EXTRACT; SLIM 339; UNCLASSIFIED DRUG; ANTIOBESITY AGENT; PANTOTHENIC ACID; SLIM339;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SELF ADMINISTRATION; FEMALE; GARCINIA CAMBOGIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MATRICARIA; MEDICINAL PLANT; OBESITY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; WEIGHT REDUCTION; BODY WEIGHT; MIDDLE AGED; PHYTOTHERAPY;

CANANGA ODORATA; GARCINIA CAMBOGIA; LAVANDULA ANGUSTIFOLIA; MATRICARIA CHAMOMILLA; ROSA X DAMASCENA;

ADULT; ANTI-OBESITY AGENTS; BODY WEIGHT; DOUBLE-BLIND METHOD; FEMALE; GARCINIA CAMBOGIA; HUMANS; MALE; MIDDLE AGED; OBESITY; PANTOTHENIC ACID; PHYTOTHERAPY; PLANT EXTRACTS;

EID: 37849012505     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2231     Document Type: Article

References (24)

1. Commission of the European Communities. 1990. CPMP Working Party on Efficacy of Medicinal Products. Good Clinical Practice for Trials on Medicinal Products in the European Community - Document III/3976/88EN. Commission of the European Communities: Brussels.
2. Considine RV, Sinha MK, Heiman ML et al. 1996. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 334: 292-295.
3. Finer N. 2002. Pharmacotherapy of obesity. Best Pract Res Clin Endocrinol Metab 16: 717-742.
4. Friedman JM, Halaas JL. 1998. Leptin and the regulation of body weight in mammals. Nature 395: 763-770.
5. Hayamizu K, Hirakawa H, Oikawa D et al. 2003. Effect of Garcinia cambogia extract on serum leptin and insulin in mice. Fitoterapia 74: 267-273.
6. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. 2004. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. J Am Med Assoc 291: 2847-2850.
7. Heymsfield SB, Allison DB, Vasselli JR, Pietrobelli A, Greenfield D, Nunez C. 1998. Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomised controlled trial. J Am Med Assoc 280: 1596-1600.
8. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. 1995. ICH Harmonised Tripartite Guideline. Structure and Content of Clinical Study Reports E3. Current Step 4 Version 30. November 1995. ICH: Geneva, 1-41.
9. Ishihara K, Oyaizu S, Onuki K, Lim K, Fushiki T. 2000. Chronic (-)-hydroxycitrate administration spares carbohydrate utilisation and promotes lipid oxidation during exercise in mice. J Nutr 130: 2990-2995.
10. Jena BS, Jayaprakasha GK, Singh RP, Sakariah KK. 2002. Chemistry and biochemistry of (-)-hydroxycitric acid from Garcinia. J Agric Food Chem 50: 10-22.
11. Leung LH. 1995. Pantothenic acid as a weight-reducing agent: fasting without hunger, weakness and ketosis. Med Hypotheses 44: 403-405.
12. Mattes RD, Bormann L. 2000. Effects of (-)-hydroxycitric acid on appetitive variables. Physiol Behav 71: 87-94.
13. Morgan JF, Reid F, Lacey JH. 1999. The SCOFF questionnaire: assessment of a new screening tool for eating disorders. Br Med J 319: 1467-1468.
14. National Institutes of Health. 1998. NIH Clinical Guidelines on the Identification, Evaluation and Treatment of Overweight and Obesity in Adults: The Evidence Report. US Government Printing Office: Washington.
15. Ohia SE, Awe SO, LeDay AM, Opere CA, Bagchi D. 2001. Effect of hydroxycitric acid on serotonin release from isolated rat brain cortex. Res Commun Mol Pathol Pharmacol 109: 210-216.
16. Ohia SE, Opere CA, LeDay AM, Bagchi M, Bagchi D, Stohs SJ. 2002. Safety and mechanism of appetite suppression by a novel hydroxycitric acid extract (HCA-SX). Mol Cell Biochem 238: 89-103.
17. Opala T, Rzymski P, Pischel I, Wilczak M, Wozniak J. 2006. Efficacy of 12 weeks supplementation of a botanical extract-based weight loss formula on body weight, body composition and blood chemistry in healthy, overweight subjects - a randomised double-blind placebo-controlled clinical trial. Eur J Med Res 11: 343-350.
18. Pittler MH, Schmidt K, Ernst E. 2005. Adverse events of herbal food supplements for body weight reduction: systematic review. Obes Rev 6: 93-111.
19. Preuss HG, Bagchi D, Bagchi M, Rao CVS, Dey DK, Satyanarayana S. 2004. Effects of a natural extract of (-)-hydroxycitric acid (HCA-SX) and a combination of HCA-SX plus niacin-bound chromium and Gymnema sylvestre extract on weight loss. Diabetes Obesity Metab 6: 171-180.
20. Roy S, Rink C, Khanna S et al. 2004. Body weight and abdominal fat gene expression profile in response to a novel hydroxycitric acid-based dietary supplement. Gene Expr 11: 251-262.
21. Shara M, Ohia SE, Yasmin T et al. 2003. Dose- and time-dependent effects of a novel (-)-hydroxycitric acid extract on body weight, hepatic and testicular lipid peroxidation, DNA fragmentation and histopathological data over a period of 90 days. Mol Cell Biochem 254: 339-346.
22. Williamson EM. 2001. Synergy and other interactions in phytomedicines. Phytomedicine 8: 401-409.
23. World Health Organization. 1998. Obesity. Preventing and Managing the Global Epidemic. Report of a WHO Consultation on Obesity. WHO/NUT/NCD/981. WHO: Geneva.
24. World Medical Association. 2000. Declaration of Helsinki. Ethical Principles for Medical Research involving Human Subjects. 18th WMA General Assembly Helsinki, Finland, June 1964; 52nd WMA General Assembly Edinburgh, Scotland, October 2000. JAMA, 2000; 284: 3043-3045. http://www.wma.net/e/ policy/b3.htm